Complete remission of nonresectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy, external beam radiation therapy, and 5-fluorouracil: A preliminary report

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 4, 1999, Pages 355-360

  DeNittis, Albert S ^a,d   Stambaugh, Michael D ^a   Lang, Patricia ^a   Wallner, Paul E ^a   Lustig, Robert A ^a   Dillman, Robert O ^b   Order, Stanley E ^c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^c Center for Molecular Medicine   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brachytherapy; Colloidal phosphorus 32; Nonresectable pancreatic cancer; Radiation therapy

Indexed keywords

CA 19-9 ANTIGEN; DEXAMETHASONE; FLUOROURACIL; MACROSALB I 131; PHOSPHORUS 32;

ADULT; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER INHIBITION; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; TUMOR VOLUME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BRACHYTHERAPY; CA-19-9 ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PHOSPHORUS RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION;

EID: 0033501675     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199908000-00006     Document Type: Article

References (25)

1. Michelassi F, Erroi F, Dawson PJ, et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas and distal common bile duct. Ann Surg 1989;210:544-53.
2. Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil). and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705-10.
3. Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 1985;56:2563-8.
4. Klaassen DJ, MacIntyre JM, Catton GE, et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil. An Eastern Cooperative Oncology Group study. J Clin Oncol 1985;3:373-78.
5. Lawrence TS, Chang EY, Hertel L, et al. Gemcitabine radiosensitizes human pancreas cancer cells [abstract 3855]. Proc Am Assoc Cancer Res 1994;35:647.
6. Moertel CT, Childs DS, Reitemeir RJ, et al. Combined 5-Fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-7.
7. Moore M, Andersen J, Burris H, et al. A randomized trial of gemcytabine versus 5-FU as first-line therapy in advanced pancreatic cancer [abstract]. Proc Am Soc Clin Oncol 1995;14:199.
8. Komaki R, Wadler S, Peters MS, et al. High dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (RTOG 8801) Cancer 1992;69:2807-12.
9. Siegel JA, Zeiger LS, Order SE, Wallner PE. Quantitative bremsstrahlung single photon emission computer tomographic imaging: use for volume activity and absorb dose calculations. Int J Radiat Oncol Biol Phys 1995;31:953-8.
10. Siegel JA, Whyte-Ellis S, Zeiger LS, et al. Bremsstrahlung SPECT imaging and volume quantification with 32 phosphorus. Antib Immunoconj Radiopharm 1994;7:1-10.
11. Miller TR, Fuller LM. Radiation therapy of carcinoma of the pancreas. Am J Roentgenol 1958;80:787-92.
12. Pack GT, McNeer G. Radiation treatment of pancreatic cancer. Am J Roentgenol 1938;40:708-14.
13. Dobelbower RR, Strubler KA, Suntharalingham N. Treatment of cancer of the pancreas with high-energy photons and electrons. Int J Radiat Oncol Biol Phys 1977;1:141-6.
14. Gunderson LL, Martin JK, Kvols LK, et al. Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 1987;13:319-29.
15. Mohiuddin M, Regine WF, Stevens J, et al. Combined intraoperative radiation and peri-operative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 1995;13:2764-8.
16. Shipley WU, Wood WC, Tepper JE, et al. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg 1984;200:289-96.
17. Nishimura A, Sakata S, Ida K, et al. Evaluation of intraoperative radiotherapy for carcinoma of the pancreas: prognostic factors and survival analyses. Radiat Med 1988;6:85-91.
18. Fortner JG, D'Angio GJ, Hilaris BS, et al. Iodine 125 implantation for unresectable cancer of the pancreas. Postgrad Med 1970;47: 226-30.
19. Whittington R, Solin L, Mohiuddin M, et al. Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 1984;54:1991-8.
20. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80:751-62.
21. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreatico-duodenectomies without mortality. Ann Surg 1993;217:430-8.
22. Whittington R, Dobelbower RR, Mohiuddin M, et al. Radiotherapy of unresectable pancreatic carcinoma: a six year experience with 104 patients. Int J Radiat Oncol Biol Phys 1981;7:1639-44.
23. Kamthan AG, Morris JC, Dalton J, et al. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 1997;15:2920-7.
24. Order SE, Siegel JA, Principato R, et al. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study. Int J Radiat Oncol Biol Phys 1996;36:1-10.
25. Order SE, Lustig R, Principato R, et al. A new method for delivering radioactive cytotoxic agents in solid cancers. Int J Radiat Oncol Biol Phys 1994;30:715-20.